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Objectives The goal of this study was to characterize a variant in the SCN5A gene that encodes the alpha-subunit of the
cardiac sodium channel, Nav1.5, which was identified in 1 large kindred with dilated cardiomyopathy (DCM) and
multiple arrhythmias, including premature ventricular complexes (PVCs).
Background Treatment guidelines for familial DCM are based on conventional heart failure therapies, and no gene-based
interventions have been established.
Methods Family members underwent clinical evaluation and screening of the SCN5A and LMNA genes. Cellular electrophysiol-
ogy and computational modeling were used to determine the functional consequences of the mutant Nav1.5 protein.
Results An R222Q missense variant located in a Nav1.5 voltage-sensing domain was identified in affected family mem-
bers. Patch-clamp studies showed that R222Q Nav1.5 did not alter sodium channel current density, but did left
shift steady-state parameters of activation and inactivation. Using a voltage ramp protocol, normalized current
responses of R222Q channels were of earlier onset and greater magnitude than wild-type channels. Action po-
tential modeling using Purkinje fiber and ventricular cell models suggested that rate-dependent ectopy of Pur-
kinje fiber origin is the predominant ventricular effect of the R222Q variant and a potential cause of DCM. In
R222Q carriers, there were only modest responses to heart failure therapies, but PVCs and DCM were substan-
tially reduced by amiodarone or flecainide, which are drugs that have sodium channel-blocking properties.
Conclusions The R222Q SCN5A variant has an activating effect on sodium channel function and is associated with reversible ven-
tricular ectopy and DCM. Elucidation of the genetic basis of familial DCM can enable effective gene-targeted therapy
to be implemented. (J Am Coll Cardiol 2012;60:1566–73) © 2012 by the American College of Cardiology
Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.05.050Dilated cardiomyopathy (DCM) is associated with significant
morbidity and mortality, and is caused by inherited gene
variants in a substantial proportion of cases. Familial DCM is
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012, accepted May 1, 2012.clinically variable and genetically heterogeneous, with at least
40 disease genes reported to date (1). Identification of the
genetic basis of DCM provides an opportunity for early
diagnosis and preventative intervention in genotype-positive
family members. However, the current reality is that mutations
in most of the known disease genes are uncommon, and the
molecular defects underpinning DCM in the majority of
families (70%) are unknown (1,2). Moreover, no effective
disease gene-targeted therapies have been established for clin-
ical use.
Mutations in the SCN5A gene that encodes the cardiac
sodium (Na) channel alpha-subunit, Nav1.5, cause a variety
of arrhythmic disorders, including long QT syndrome, Bru-
gada syndrome, ventricular tachycardia, sick sinus syndrome,
atrial standstill, conduction system abnormalities (CD), and atrial
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October 16, 2012:1566–73 SCN5A Mutations and Familial Dilated Cardiomyopathyfibrillation (AF). SCN5Amutations have also been associated with
DCM that is typically preceded by a prodrome of CD or AF, a
similar phenotype to that observed with mutations in the LMNA
gene, which encodes nuclear lamin A/C (3–5).
A large Caucasian kindred with a clinical diagnosis of DCM
and CD was referred to our laboratory for molecular genetics
analysis. Detailed phenotype evaluation demonstrated that multi-
ple electrocardiographic (ECG) abnormalities were present. In
particular, frequent polymorphic ventricular ectopy was a promi-
nent and early manifestation, raising the possibility of a causal
relationship with the development of DCM. We re-sequenced
the SCN5A and LMNA genes and identified a heterozygous
missense R222Q SCN5A variant that segregated with dis-
ease status in the kindred. Functional characterization of the
R222Q variant showed an activating effect on cardiac Na
channel function, and in a ventricular cell model, these
effects were predicted to induce premature ventricular com-
plexes (PVCs) predominantly of Purkinje fiber cell origin.
The availability of genotype results changed the medical
management of affected family members, and administra-
tion of drugs with Na channel-blocking properties enabled
oth ventricular ectopy and DCM to be reversed.
ethods
linical evaluation. Informed written consent was ob-
ained from all participants, and the study protocol was
pproved by the institutional Human Research Ethics
ommittee. The proband and participating family members
16 years of age were evaluated by history and physical
xamination, 12-lead ECG, and transthoracic echocardiog-
aphy. The results of additional cardiac investigations per-
ormed for clinical indications, including Holter monitor
nd electrophysiology studies (EPS), were obtained from
edical records. One hundred unrelated healthy Caucasian
olunteers comprised the control group.
enetic analysis. Genomic DNA was isolated from pe-
ipheral blood samples. Protein-coding sequences of the
CN5A and LMNA genes were amplified by polymerase
hain reaction and re-sequenced using an ABI PRISM 3730
NA Analyzer (Applied Biosystems, Foster City, Califor-
ia). The R222Q SCN5A substitution results in loss of a
inf1 site and was independently confirmed by restriction
nzyme digestion.
ellular electrophysiology and modeling. Chinese ham-
ter ovary (CHO) cells were transfected with cDNA clones
ncoding wild-type (WT) and R222Q Nav1.5 plus WT
av1. Cardiac Na channel currents (INa) were recorded
sing conventional patch-clamp techniques. To investigate
he functional consequences of mutant channels, WT and
222Q Nav1.5 channels were modeled using Hodgkin-
uxley formalism as described (6), and WT and mutant
odels were incorporated into Purkinje cell (6) and ventric-lar cell (7) models (Online Appendix). sesults
amily phenotype. Forty-two
ndividuals in 2 related large kin-
reds (Family HY) underwent
linical evaluation and genetic
esting (Fig. 1, Table 1). The
amily phenotype was character-
zed by a high prevalence of atrial
nd ventricular arrhythmias, with
CM occurring mainly in males.
striking feature of the ECG
racings of family members studied
n sinus rhythm was the relative
aucity of normally conducted si-
us beats, with the majority of
eats being PVCs, including nar-
ow PVCs of probably high septal
rigin that had varying morphol-
gy and axis, as well as wide PVCs
f left and right bundle branch
ype (Figs. 1B to 1D). Premature
trial complexes (PACs) and ac-
elerated junctional rhythms were
lso seen. Six individuals had documented AF, and 3 individuals
eceived pacemakers for symptomatic bradycardia or complete
eart block in later adult life. EPS results were available in 4 cases
nd uniformly showed multiple PVC foci in the left and right
entricles, with no inducible ventricular arrhythmias. Five individ-
als had prophylactic implantation of cardioverter-defibrillators
ICDs).
Eight individuals had a diagnosis of DCM (Table 1). In 2
symptomatic young males, DCM was detected only as a result
f family screening. A history of palpitations that predated
CM diagnosis was elicited in all other cases. DCM was
resent in 7 of the 10 genotype-positive males but in only 1 of the
genotype-positive females. Myocardial fibrosis was excluded in 2
ndividuals with severe DCM by magnetic resonance imaging
IV-27) and cardiac biopsy (IV-34), respectively.
dentification of R222A SCN5A variant. The coding
egions of the SCN5A and LMNA genes were re-sequenced
n the proband’s DNA (III-10; Fig. 1A) and a heterozygous
65GA change in the SCN5A gene was identified that
lters the amino acid at codon 222 from arginine (R) to
lutamine (Q). The R222 residue is located in a voltage-
ensing S4 region of Nav1.5 and has high homology across
ifferent members of the human Na channel gene family and
ifferent species (Online Fig. 1). Fourteen individuals were
enotype-positive, and 3 deceased individuals (II-5, III-5,
II-7) were obligate carriers. Sixteen of these 17 gene variant
arriers were clinically affected, with the exception being a
6-year-old male (III-12) who had a normal ECG and
chocardiogram. R222Q is a recurrent rare variant identified in
DCM families (8–11). This variant was not found in 200
ontrol chromosomes (this study), in 506 control chromo-
Abbreviations
and Acronyms
AF  atrial fibrillation
CD  conduction system
abnormalities
CHO  Chinese hamster
ovary
DCM  dilated
cardiomyopathy
ECG  electrocardiogram
EPS  electrophysiology
studies
ICD  implantable
cardioverter-defibrillator
INa  Na
 channel current
Na  sodium
PAC  premature atrial
complex
PVC  premature
ventricular complex
WT  wild-typeomes in a previous report (8), or in the 1000 Genomes and
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SCN5A Mutations and Familial Dilated Cardiomyopathy October 16, 2012:1566–73dbSNP databases. None of the R222Q carriers had the
common SCN5A variant, H558R, which has been shown to
modify the functional effects of R222Q in vitro (12).
Activating effect of R222A SCN5A on INa activity.
Given its location in a voltage-sensor domain, the R222Q
variant is predicted to affect channel gating. CHO cells
expressing WT Nav1.5 or R222Q Nav1.5 had similar mean
current densities, but in R222Q channels, the midpoints of
the voltage-dependence of activation and inactivation were
left-shifted by 6.3 and 6.2 mV, respectively (Fig. 2A). Other
kinetic parameters were not altered (Online Figs. 2 and 3).
A consequence of the left-shifted activation and inactivation
curves was that the area beneath the intersection of these
curves (the “window” current) spanned a more negative
membrane potential area (Fig. 2A, inset). To determine the
effects of increased window current, we examined the re-
sponses of WT and R222Q channels to a ramp voltage-
protocol (13) analogous to the diastolic depolarization seen in
Purkinje fiber cells. During a voltage ramp, in which the
membrane potential was gradually changed between –120
and 40 mV at 0.16 mV/ms, the normalized current
response of the R222Q channels opened at more negative
potentials and had relatively greater peak current than that
Figure 1 Phenotype Characteristics of R222Q SCN5A
(A) Family HY pedigree with the proband indicated by an arrow. Phenotypes are de
symbols, right half, upper quadrant), dilated cardiomyopathy (DCM) (solid symbol
The presence () or absence (–) of the R222Q allele is shown. For untested oblig
rhythm strip (lead II) from individual IV-16 showing P waves of varying morphologie
morphologies and axis. (C) ECG rhythm strip (lead V6) from individual IV-11 showin
lar complexes (PVCs) with different morphologies, and an accelerated junctional rh
PVCs, and wide LBBB-type PVCs with variable axis.observed in WT channels (Fig. 2B).Purkinje fiber and ventricular cell modeling. To investi-
gate the functional consequences of having Na channels
open at more negative potentials, we incorporated the
R222Q Nav1.5 properties into a mathematical model of a
Purkinje fiber cell (6). The original Stewart model displays
automaticity with a frequency just below 1 Hz. When paced
with 1-ms stimuli of 52 pA/pF at a frequency higher than
the intrinsic rate of the model, each stimulus is captured and
evokes an action potential. In contrast, the heterozygous
WT/R222Q model showed a higher rate of spontaneous
activity (79 beats/min), and pacing at 1 Hz resulted in
grossly disorganized action potential patterns (Fig. 2D).
Similar to the WT model, pacing at higher rates in the
R222Q model resulted in stimulus capture and a regular 1:1
relationship with each action potential (Fig. 2E). These
findings suggest that PVCs associated with the R222Q
variant may result from increased automaticity of Purkinje
fiber cells, and that these effects are rate dependent. To
simulate the effects of Na channel-blocking drugs, decre-
ental INa densities were evaluated in WT and WT/
R222Q heterozygote model cells. A 33% reduction of INa
decreased the spontaneous rate of the WT/R222Q hetero-
zygote cell to 65 beats/min, and a 50% reduction decreased
as ventricular ectopy (solid symbols, left half), conduction abnormalities (solid
t half, lower quadrant), unaffected (open symbols), unknown (gray symbols).
rriers, genotypes are shown within parentheses. (B) Electrocardiographic (ECG)
multiple narrow QRS complexes dissimilar to the dominant rhythm with varying
s rhythm, 2 normal axis left bundle branch block (LBBB)-type premature ventricu-
(D) ECG rhythm strip (lead II) from IV-10 showing sinus rhythm, narrow right axisnoted
s, righ
ate ca
s and
g sinu
ythm.the rate to 50 beats/min, which enabled the cell to regain
Clinical Features of Genotype-Positive Family MembersTable 1 Clinical Features of Genotype-Positive Family Members
ID
Age (yrs)/
Sex
HR*
(beats/min)
PR
Interval (ms)
QT/QTc
(ms) CD Arrhythmias
PVCs/PSVCs
(% Total QRS)* Devices DCM Other
II-5 56/F† NA NA NA NA Nonspecified NA No NA Sudden death
II-9 88/M Paced NA NA Third-degree AVB,
RBBB
PVC, NSVT, PAC,
PmAF
NA PPM No
II-11 85/F Paced NA NA First-degree AVB,
LBBB
PVC, NSVT, JR,
PAC, PAF
NA PPM No HT, DM, IHD
III-5 59/M† 63 161 391/400 No PVC, PAF NA No NA Stroke†, IHD
III-6 60/M 72 NA 370/405 No PVC, PmAF 27,803 (27%)/NA No Yes Stroke
III-7 38/M† NA NA NA NA NA NA No Yes Heart failure†
III-10 62/F 76 180 380/428 No PVC, NSVT, PAC,
PAF
 PPM No EPS: multifocal PVCs RVLV,
no inducible VT/VF
III-12 56/M 75 170 362/404 No No NA No No HT, DM
III-17 58/F 77 160 466/528 RBBB PVC 1,276 (1%)/138 (1%) No No HT, DM
IV-10 24/M 75 138 313/349 No PVC, NSVT, PAC 78,492 (58%)/12,566 (9%) ICD Yes
IV-11 25/F 78 100 376/428 No PVC, JR, PAC 395 (1%)/5,255 (4%) No No
IV-13 31/M 93 160 360/448 No PVC, NSVT, PAC,
PAF
20,600 (15%)/ ICD Yes
IV-16 21/F 94 160 304/401 No PVC, JR  No Yes
IV-21 41/F 112 139 348/475 No PVC, NSVT, PAC 58,000 (33%)/23,500 (13%) ICD No
IV-26 27/M 92 160 368/456 RBBB PVC, JR, PAC 2,911 (3%) 1,463 (1%) No Yes EPS: multifocal PVCs (mainly RV apex,
LVOT), no inducible VT/VF, frequent
JR, PACs with intermittent LBBB
aberrancy
IV-27 25/M 96 162 345/436 No PVC, NSVT, PAC 16,295 (12%)/18,812 (14%) ICD Yes EPS: multifocal PVCs (RVLV),
no inducible VT/VF
IV-34 30/M 123 156 336/482 No PVC, NSVT, PAC 48,000 (30%)/NA ICD Yes EPS: multifocal PVCs
*Data obtained from electrocardiographic (ECG) or Holter recordings before amiodarone or flecainide therapy. Assessment of ECG parameters was complicated by frequent ectopy and was based on isolated sinus beats in some cases. Daily premature ventricular complex
(PVC) numbers are estimates only due to difficulty differentiating between ventricular and supraventricular premature complexes; in some cases, PVC burden was qualitatively reported as “occasional” () or “very frequent” (). †Death.
AVB atrioventricular conduction block; CD conduction system abnormalities; DCM dilated cardiomyopathy; DM diabetes mellitus; EPS electrophysiology studies, HR heart rate; HT hypertension; ICD implantable cardioverter-defibrillator; IHD ischemic
heart disease; JR  accelerated junctional rhythm; LBBB  left bundle branch block; LV  left ventricle; LVOT  left ventricular outflow tract; NA  not available; NSVT  nonsustained ventricular tachycardia; PAC  premature atrial complex; PAF  paroxysmal atrial
fibrillation; PmAF  permanent atrial fibrillation; PPM  permanent pacemaker; PSVC  premature supraventricular complex; RBBB  right bundle branch block; RV  right ventricle; VT/VF  ventricular tachycardia/ventricular fibrillation.
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SCN5A Mutations and Familial Dilated Cardiomyopathy October 16, 2012:1566–73regular pacing with a 1-Hz stimulus (Fig. 2D). To deter-
mine whether the effects of R222Q Nav1.5 were specific for
Purkinje fiber cells, we also incorporated our modified Na
channels into a ventricular cell model (7). There were no
significant differences between WT and homozygous
R222Q model cells when paced at rates between 2 and 0.5
Hz. We could, however, elicit a subtle difference by intro-
ducing an artificial current stimulus, analogous to a delayed
afterdepolarization, during the diastolic interval. A smaller
current stimulus could elicit a premature action potential in
the R222Q but not in WT cells (Online Fig. 4).
Phenotype-modifying interventions. The rate-dependence
predicted by the modeling studies was supported by clinical
observations in affected family members with PVC frequency
increased during periods of low heart rate at rest and at night,
and reduced by high heart rates during exercise. During EPS,
acute reductions in PVC numbers were seen following rapid
Figure 2 Electrophysiological Characteristics of R222Q SCN5A
(A) Both steady-state activation and steady-state inactivation curves in R222Q cha
resulting in a left-shifted and increased window current (inset). (B) Averaged norm
slopes. R222Q channels activate at more negative potentials and have larger norm
R222Q sodium channels in a Purkinje cell model closely resemble experimental re
ing the diastolic interval during pacing at 1 Hz (D, middle tracing). Ectopic beats
ple, by Na channel blocking drugs (D, lower tracing) or during pacing at 2 Hz (E)pacing (cycle length 450 ms), or intravenous administrationf isoproterenol, metoprolol (doses 5 mg), or flecainide. All
amily members diagnosed with DCM were treated with
tandard heart failure therapy, beta-blockers, and/or
ngiotensin-converting enzyme inhibitors, but these drugs had
odest or no benefits (Figs. 3E and 3F, Online Table 1). In
ontrast, addition of amiodarone (IV-10, IV-27) or flecainide
IV-21, IV-34), drugs that have Na channel-blocking prop-
erties (14,15), resulted in a dramatic reduction of PVC num-
bers and recovery of normal left ventricular function in those
individuals with DCM (Figs. 3A to 3F, Online Table 1). The
effects on PVCs occurred early, after treatment was started,
whereas left ventricular remodeling changes occurred more
slowly and took approximately 6 months.
Discussion
R222Q is a recurrent SCN5A variant identified to date in 4
(red lines) are left-shifted in comparison to wild-type (WT; black lines) channels,
current responses from WT (n  3) and R222Q (n  3) cells at different ramp
current amplitude compared with WT channels. (C) Simulated effects of WT or
seen in B. In heterozygous R222Q/WT cells, ectopic beats (asterisks) occur dur-
ppressed with a 50% reduction in sodium (Na) channel current (INa), for exam-nnels
alized
alized
sults
are su
.large kindreds with DCM. In this study, we found that the
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October 16, 2012:1566–73 SCN5A Mutations and Familial Dilated Cardiomyopathyclinical phenotype associated with R222Q SCN5A included
multiple arrhythmias, suggestive of enhanced automaticity
in the atrium and ventricles. Our data provided new
perspectives on the biophysical properties of R222Q Nav1.5
and showed that it has activating effects on INa, which in the
entricle predispose to PVCs mainly of Purkinje fiber
rigin. These findings raise interesting questions about the
ause of DCM and highlight the value of genotype infor-
ation as a guide to family management.
The high prevalence of PVCs was a prominent feature of
Figure 3 Effects of Na Channel-blocking Treatment
Effects of Na channel-blocking treatment on ECG (A,B) and echocardiographic (C,
and echocardiography showed severe DCM (C). He was started on heart failure th
mg/day. After 4 months, he continued to have severe left ventricular dysfunction,
QRS complexes. An implantable cardioverter-defibrillator (ICD) was implanted and
only 22 PVCs (1% total QRS complexes) on 24-h monitoring. Follow-up echocard
drug therapy were evaluated in those family members with DCM who had serial Ho
and/or angiotensin-converting enzyme inhibitors alone (n  4; red symbols, dashe
(n  2) or flecainide (n  1) showed resolution of PVCs (E) and normalization of lhis family’s phenotype. PVCs are ectopic impulses that hrise from ventricular myocardium and can result from focal
ites with increased automaticity, re-entrant circuits that
ccur in regions of heterogeneous conduction (e.g., border
ones between infarcted and normal tissue) or from trig-
ered activity due to early or late afterdepolarizations.
lthough PVCs are considered benign in healthy adults
16,17), PVCs that are frequent (60/h) or complex (mul-
iple morphologies or repetitive patterns) have been associ-
ted with an increased long-term risk of malignant ventric-
lar arrhythmias and sudden death (17,18). PVCs have a
ameters. A 22-year-old male had frequent complex ventricular ectopy on ECG (A)
with carvedilol 25 mg twice daily, ramipril 10 mg/day, and spironolactone 25
Holter monitor showed 70,000 PVCs, representing 58% of the daily number of
arone 100 mg was started. ECG performed 6 weeks later was normal (B), with
y showed improvement in ventricular function after 6 months (D). The effects of
d echocardiographic studies. When compared with those on beta-blockers
s), family members (n  3; green symbols, solid lines) who received amiodarone
tricular ejection fraction (LVEF) (F). Abbreviations as in Figure 1.D) par
erapy
and a
amiod
iograph
lter an
d line
eft venigher prevalence in patients with reduced ejection fraction,
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SCN5A Mutations and Familial Dilated Cardiomyopathy October 16, 2012:1566–73and although often regarded as a complication of DCM,
there has been increasing recognition that a high burden of
PVCs may independently impair cardiac contraction and
promote DCM (“ventricular ectopy-induced DCM”)
(19,20). The risk of developing DCM increases with PVC
burden, with a cutoff value of 24% estimated in 1 study
(20). This threshold level can be variable, however, and
lower numbers of PVCs may be sufficient to promote DCM
in individual cases. The precise mechanisms underpinning
ectopy-induced DCM are unclear, and may be related to
factors such as dyssynchronous myocardial contraction or
increased sympathetic nervous system activation (21).
PVCs of left and right ventricular origin have previously
been associated with SCN5A mutations (22). Patch-clamp and
modeling data in Family HY point to hyperexcitability of
Purkinje fiber cells due to increased INa window current as a
mechanism for PVC genesis. This differs from gain-of-
function SCN5A mutations associated with long QT syndrome
3 that disrupt fast inactivation of INa, prolonging the action
otential duration and increasing the propensity for early
fterdepolarizations (15). In Family HY, there were multiple
VC morphologies, with a high prevalence of narrow com-
lexes of probable high septal fascicular origin (23), as well as
ider complexes suggesting distal Purkinje fiber or ventricular
rigin. These multiple morphologies made estimation of the
aily PVC numbers difficult to assess on Holter monitor
ecordings because ventricular and supraventricular complexes
ere not always readily distinguished. PVCs may also be
onfused with aberrantly conducted PACs, which were dem-
nstrated during EPS in 1 family member. Nevertheless, ECG
nd Holter tracings clearly showed a massive number of PVCs,
aising the possibility that ventricular ectopy could have an
mportant role in causing DCM. Factors supporting ventricu-
ar ectopy-induced DCM include the history of palpitations
hat preceded DCM in many cases, and the dramatic reduc-
ions in PVC numbers before improvements in contraction as
result of amiodarone or flecainide therapy. PVCs are com-
only seen in patients with myopathic hearts, and it is equally
lausible that at least some of the PVCs, especially those of
entricular origin, might have arisen as a consequence of
CM. Similar arguments can be made for the contribution of
F, which may be a cause or effect of DCM. Only 2 of the 6
amily members with AF developed DCM, and there was no
lear history of AF predating DCM in either case.
Altered INa activity may directly impair ventricular func-
ion independently of effects of PVCs or AF. Many of the
CN5A variants associated with DCM reduce INa density or
exhibit rate-dependent reductions of Na current (12,24–26).
Reductions in myocardial INa have been observed in human
heart failure (27) and in transgenic mice with DCM due to
overexpression of the transcriptional repressor, Snail (28).
Previous cellular electrophysiology studies have shown that the
R222Q variant does not reduce INa when expressed alone in
transfected cells (12), and our data are concordant with this.
R222Q Nav1.5 was reported to reduce INa when co-expressed
with the common H558R SCN5A variant (12). However, bbecause none of the genotype-positive members of Family HY
were H558R carriers, the modifying effects of this variant were
not clinically relevant. Gain-of-function effects on INa have
been seen with some DCM-causing SCN5A variants, includ-
ing the R814W variant, which increases window current (26),
analogous to our findings with R222Q. It has been proposed
that the increased window current results in augmented dia-
stolic Na fluxes, and that this could promote DCM by
ausing regional heterogeneity in myocardial impulse propaga-
ion or by altering intracellular Na and Ca2 homeostasis.
Although myocardial structural defects can contribute to
DCM associated with SCN5A variants (29), ventricular fibrosis
was excluded in 2 members of Family HY with severe DCM
who underwent magnetic resonance imaging and cardiac
biopsy, respectively.
An intriguing question in Family HY is why only half of
the genotype-positive individuals developed DCM. There
was a clear sex difference, with DCM occurring in 6 of the
7 living clinically affected males, but only in 1 of 6 females.
Sex differences in ion channel gene expression (30) and in
ECG parameters (31) have been observed, and may account
for differential susceptibility to ventricular arrhythmias.
From adolescence onwards, women have faster heart rates
and longer QTc intervals, with less intraventricular conduc-
tion disturbances, QRS prolongation, and QT dispersion
than men. Although these changes may increase the risk of
arrhythmias associated with long QT-causing SCN5A vari-
ants (32), they may be relatively protective in the setting of
the R222Q variant, which was predicted to have less
Purkinje fiber excitability at high heart rates.
The cause of the CD in a subset of family members is
unclear. Conduction system defects are often seen with loss-
of-function SCN5A mutations, but may occur with activating
SCN5A mutations (24,25,33). Age-related degenerative effects
and/or changes in Nav1.5 expression, as well as additional
genetic variants may be contributing factors.
Clinical guidelines for familial DCM recommend that
affected individuals receive standard pharmacological man-
agement as indicated by the severity of heart failure and its
complications. No specific gene-based treatment strategies
have been devised (34). Conventional heart failure therapies
were relatively ineffective, however, in members of Family
HY, whereas drugs with Na channel-blocking properties
nabled the phenotype to be reversed. Amiodarone has
ultiple actions, including effects on K, Ca2, and Na
channels (14), and is often used to treat ventricular ectopy.
Its long-term use may not be tolerated, however, due to the
high risk of adverse effects (35). Flecainide is an alternative
option, because it is a more selective Na channel blocker
ith a lower side-effect profile overall, but this drug is
enerally contraindicated in patients with reduced left ven-
ricular function due to potential proarrhythmic effects (35).
lecainide was well-tolerated and markedly reduced PVC
umbers in 2 family members, 1 of whom had DCM and an
CD. ICDs were implanted prophylactically in 5 family mem-
ers with frequent complex PVCs, but the availability of
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2
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2
2
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3
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early ICD implantation. One prudent approach to manage-
ment of family members without ICDs would be to start with
amiodarone until DCM resolves, then switch to flecainide for
ongoing maintenance therapy. The responses to amiodarone or
flecainide therapy were quite remarkable, and the kindred
described here provided an exemplary case in which elucidation
of the genetic basis for familial forms of DCM can enable
effective disease-modifying therapy to be implemented.
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For an expanded Methods section and a supplemental table and figures,
please see the online version of this article.
